UBC Faculty Research and Publications

Does SPRINT change our approach to blood pressure targets? Therapeutics Initiative (University of British Columbia)

Description

Therapeutics Letter 98 reviews Cochrane systematic review evidence in considering whether SPRINT should change the approach to blood pressure targets. Conclusions: At the present time, lower BP targets (≤ 135/85 mmHg) have not been demonstrated to reduce mortality or total serious adverse events as compared with standard BP targets (≤ 140-160/90-100 mmHg). Careful analysis of the SPRINT trial reveals that benefits of a lower blood pressure target in high-risk nondiabetic people do not outweigh harms. Critical appraisal of systematic reviews and clinical trial reports often leads to interpretation and conclusions different from initial impressions.

Item Citations and Data

Rights

Attribution-NonCommercial-NoDerivatives 4.0 International